8/9/2022 8:10:07 AM
Corbus Pharma Q1 Net Loss $13.2 Mln Or $0.11/shr Vs Net Loss Of $17.1 Mln Or $0.15/shr Prior Year
5/11/2022 8:08:19 AM
Corbus : Preclinical Data For CRB-601 Demonstrate Significant Effects On Inhibiting Tumor Growth
3/8/2022 8:23:37 AM
Corbus Pharma Q4 Net Loss $10.3 Mln Or $0.08/shr Vs. Net Loss Of About $8.6 Mln Or $0.10/shr Prior Year
12/7/2021 8:06:31 AM
Corbus Pharma Appoints Rachael Brake As Chief Scientific Officer
11/12/2021 8:20:17 AM
Corbus Pharma Q1 Revenue $97,000 Vs $1.23 Mln Prior Year